| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/24/2003 | WO2003059875A2 DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION |
| 07/24/2003 | WO2003059874A2 Aromatic thioether liver x-receptor modulators |
| 07/24/2003 | WO2003059873A1 Potassium channel modulators |
| 07/24/2003 | WO2003059871A1 N-alkylsulfonyl-substituted amide derivatives |
| 07/24/2003 | WO2003059855A1 Synthesis of combretastatin a-2 prodrugs |
| 07/24/2003 | WO2003059389A1 Medicinal compositions for improving oral absorption |
| 07/24/2003 | WO2003059378A2 Combined use of a glp-1 compound and another drug for treating dyslipidemia |
| 07/24/2003 | WO2003059372A2 Combined use of a glp-1 compound and a modulator of diabetic late complications |
| 07/24/2003 | WO2003059368A1 Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts |
| 07/24/2003 | WO2003059367A1 A healthful chinese traditional medicinal preparation optimizing the brain |
| 07/24/2003 | WO2003059361A1 Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium |
| 07/24/2003 | WO2003059359A1 D-tagatose as an anti-biofilm agent |
| 07/24/2003 | WO2003059357A1 Pregnane steroids for use in the treatment of cns disorders |
| 07/24/2003 | WO2003059355A1 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 07/24/2003 | WO2003059353A1 Tyrosyl derivatives and their use as p2x7 receptor modulators |
| 07/24/2003 | WO2003059348A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 07/24/2003 | WO2003059346A1 Beta-secretase inhibitors |
| 07/24/2003 | WO2003059345A1 Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 07/24/2003 | WO2003059294A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/24/2003 | WO2003059291A2 Treatment of bone disorders with skeletal anabolic drugs |
| 07/24/2003 | WO2003059289A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 07/24/2003 | WO2003059283A2 Compounds for blocking androgen receptors |
| 07/24/2003 | WO2003059276A2 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 07/24/2003 | WO2003059273A2 Antibody-avidin fusion proteins as cytotoxic drugs |
| 07/24/2003 | WO2003059270A2 Method for reducing morbidity and mortality in critically ill patients |
| 07/24/2003 | WO2003059269A2 Acridone inhibitors of impdh enzyme |
| 07/24/2003 | WO2003059266A2 Post-conditioning for the reduction of ischemic-reperfusion injury in the heart and other organs |
| 07/24/2003 | WO2003059264A2 Methods for the induction of professional and cytokine-producing regulatory cells |
| 07/24/2003 | WO2003059088A1 Stable hygroscopic compositions and methods for stabilizing hygroscopic ingredients |
| 07/24/2003 | WO2003048168A3 Trioxane derivatives as antimalaria or anticancer compounds |
| 07/24/2003 | WO2003047577A3 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 07/24/2003 | WO2003045999A3 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 07/24/2003 | WO2003045333A3 Treatment of hyperproliferative diseases using active vitamin d analogues |
| 07/24/2003 | WO2003043572A3 Methods and compositions related to irm compounds and toll-like receptor pathways |
| 07/24/2003 | WO2003032918A3 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 07/24/2003 | WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction |
| 07/24/2003 | WO2003009741A3 Methods for treating joint inflammation, pain, and loss of mobility |
| 07/24/2003 | WO2003006645A3 Method and composition for inhibiting heparanase activity |
| 07/24/2003 | WO2002099057A3 Sams modifiers of the p53 pathway and methods of use |
| 07/24/2003 | WO2002094873A3 Preparation of cholecystokinin agonists and antagonists, and their therapeutic and diagnostic use |
| 07/24/2003 | WO2002072104A3 Antihypertensive agent and cholesterol absorption inhibitor combination therapy |
| 07/24/2003 | WO2002066640A3 Zinc finger binding domains for nucleotide sequence ann |
| 07/24/2003 | WO2002059323A3 Aminoacyl trna synthetases |
| 07/24/2003 | WO2002053770A3 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 07/24/2003 | WO2002050278A3 Novel human secreted proteins and polynucleotides encoding the same |
| 07/24/2003 | WO2002049669A3 Electrically responsive promoter system |
| 07/24/2003 | WO2002049575A3 Method and composition for the treatment of diabetic neuropathy |
| 07/24/2003 | WO2002042272A3 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | WO2002036634A3 Gene regulation therapy involving ferritin |
| 07/24/2003 | WO2002019982A3 Cosmetic composition and method for reducing or preventing wrinkling |
| 07/24/2003 | US20030139605 Antiproliferative agents, treating or preventing osteoporosis, inflammation, and angiogenesis disorders, treating liver cancer |
| 07/24/2003 | US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 07/24/2003 | US20030139475 Novel tricyclic compounds and drug compositions containing same |
| 07/24/2003 | US20030139463 Anticancer agents; antiarthritic agents |
| 07/24/2003 | US20030139462 Antiinflammatory agents; autoimmune disease; antiarthritic agents |
| 07/24/2003 | US20030139452 Pyrazole-derived kinase inhibitors and uses thereof |
| 07/24/2003 | US20030139448 Antidiarrhea agents; gastrointestinal disorders |
| 07/24/2003 | US20030139447 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 07/24/2003 | US20030139446 Reacting with acid mixed with solvent; salt formation |
| 07/24/2003 | US20030139443 Anxiolytic agents; veterinary medicine |
| 07/24/2003 | US20030139439 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 07/24/2003 | US20030139435 N-heterocyclic inhibitors of TNF-alpha expression |
| 07/24/2003 | US20030139434 Combinations comprising dipeptidylpeptidase-iv inhibitor |
| 07/24/2003 | US20030139433 Incontinence |
| 07/24/2003 | US20030139428 Purine derivatives for treatment of gastrointestinal disorders, immunological disorders, neurological disorders |
| 07/24/2003 | US20030139425 Piperazine derivatives and their use as anti-inflammatory agents |
| 07/24/2003 | US20030139423 Central nervous system disorders; psychological disorders |
| 07/24/2003 | US20030139419 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 07/24/2003 | US20030139418 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
| 07/24/2003 | US20030139417 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof |
| 07/24/2003 | US20030139414 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 07/24/2003 | US20030139413 Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical composition containing them |
| 07/24/2003 | US20030139410 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 07/24/2003 | US20030139407 Efficient synthesis of 5-heteroatom-containing -pyrazoles |
| 07/24/2003 | US20030139406 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 07/24/2003 | US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 07/24/2003 | US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders |
| 07/24/2003 | US20030139401 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139400 Controlling cell differentiation; antiinflammatory agents |
| 07/24/2003 | US20030139399 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 07/24/2003 | US20030139398 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 07/24/2003 | US20030139394 Dibenzodiazepine derivatives, their preparation and use |
| 07/24/2003 | US20030139393 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants |
| 07/24/2003 | US20030139391 Efficacious dosage regimen of galantamine that reduces side effects |
| 07/24/2003 | US20030139389 Gastrointestinal disorders, cardiovascular disorders, central nervous system disorders |
| 07/24/2003 | US20030139384 Transdermal supplying testosterone |
| 07/24/2003 | US20030139383 Respiratory system disorders |
| 07/24/2003 | US20030139382 Method of treating middle ear infections |
| 07/24/2003 | US20030139377 Bactericides; enzyme inhibitors |
| 07/24/2003 | US20030139374 Combined methods for tumor vasculature coagulation and treatment |
| 07/24/2003 | US20030139371 Drug for combating sexual dysfunctions |
| 07/24/2003 | US20030139368 Antithrombotic and/or anti-inflammatory composition combining purine activity and NSAID activity |
| 07/24/2003 | US20030139365 Expression and export of angiogenesis inhibitors as immunofusins |
| 07/24/2003 | US20030139364 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 07/24/2003 | US20030139363 Methods and compositions for RNAi mediated inhibition of viral gene expression in mammals |
| 07/24/2003 | US20030139353 Using topoisomerase inhibitor; antiarthritic agents; respiratory system disorders; skin disorders |
| 07/24/2003 | US20030139335 Diagnosis of premature infants; collagen forming |
| 07/24/2003 | US20030139323 Preradiation therapy; side effect reduction |
| 07/24/2003 | US20030138932 Comprises enzymatic glycoproteins for use as antitumor/antiproliferative agents; enzyme inhibitors; drug screening |